CCAAT-Enhancer-Binding Protein-alpha
"CCAAT-Enhancer-Binding Protein-alpha" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CCAAT-enhancer-binding protein found in LIVER; ADIPOSE TISSUE; INTESTINES; LUNG; ADRENAL GLANDS; PLACENTA; OVARY and peripheral blood mononuclear cells (LEUKOCYTES, MONONUCLEAR). Experiments with knock-out mice have demonstrated that CCAAT-enhancer binding protein-alpha is essential for the functioning and differentiation of HEPATOCYTES and ADIPOCYTES.
| Descriptor ID |
D022763
|
| MeSH Number(s) |
D12.776.260.108.124.500 D12.776.660.167.500 D12.776.930.127.124.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "CCAAT-Enhancer-Binding Protein-alpha".
Below are MeSH descriptors whose meaning is more specific than "CCAAT-Enhancer-Binding Protein-alpha".
This graph shows the total number of publications written about "CCAAT-Enhancer-Binding Protein-alpha" by people in this website by year, and whether "CCAAT-Enhancer-Binding Protein-alpha" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 1 | 2 |
| 2004 | 1 | 1 | 2 |
| 2005 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 2 | 0 | 2 |
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 1 | 2 |
| 2014 | 1 | 0 | 1 |
| 2016 | 1 | 1 | 2 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "CCAAT-Enhancer-Binding Protein-alpha" by people in Profiles.
-
Insight into the mechanism of AML del(9q) progression: hnRNP K targets the myeloid master regulators CEBPA (C/EBPa) and SPI1 (PU.1). Biochim Biophys Acta Gene Regul Mech. 2024 Mar; 1867(1):195004.
-
Activation of CDK4 Triggers Development of Non-alcoholic Fatty Liver Disease. Cell Rep. 2016 07 19; 16(3):744-56.
-
How does C/EBPa speed up cell reprogramming? Cell Cycle. 2016 09 16; 15(18):2381-2.
-
C/EBPa creates elite cells for iPSC reprogramming by upregulating Klf4 and increasing the levels of Lsd1 and Brd4. Nat Cell Biol. 2016 Apr; 18(4):371-81.
-
CCAAT/enhancer-binding protein a negatively regulates IFN-? expression in T cells. J Immunol. 2014 Dec 15; 193(12):6152-60.
-
C/EBPa poises B cells for rapid reprogramming into induced pluripotent stem cells. Nature. 2014 Feb 13; 506(7487):235-9.
-
Age-associated change of C/EBP family proteins causes severe liver injury and acceleration of liver proliferation after CCl4 treatments. J Biol Chem. 2014 Jan 10; 289(2):1106-18.
-
Increased expression of enzymes of triglyceride synthesis is essential for the development of hepatic steatosis. Cell Rep. 2013 Mar 28; 3(3):831-43.
-
Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer. Hepatology. 2013 Mar; 57(3):1098-106.
-
Ursolic acid enhances mouse liver regeneration after partial hepatectomy. Pharm Biol. 2012 Apr; 50(4):523-8.